Cynosure Group’s Encompass Health EHC Stock Holding History

Cynosure Group’s Portfolio EHC Stock Details EHC Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q1	–	Sell	-3,578	Closed	-$380K	–	281
2025 Q4	$380K	Buy	+3,578	New	+$415K	0.04%	380

Other funds holding EHC

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

VPM

Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM

T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return

VCM

Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM

Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return

Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return

T. Rowe Price Investment Management Baltimore, Maryland $145B AUM 22.78% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

AllianceBernstein Nashville, Tennessee $309B AUM 23.92% 1-Year Est. Return

Fuller & Thaler Asset Management San Mateo, California $29.7B AUM 43.33% 1-Year Est. Return

Cynosure Group's EHC Position: Q1 2026 in Review

Cynosure Group sold out of Encompass Health (EHC) in Q1 2026, closing a stake of 3,578 shares — an estimated $380K sold.

Cynosure Group first reported a position in EHC in Q4 2025 and held it in 1 quarter. The position peaked at $380K in Q4 2025. 577 funds tracked by Wall St. Rank hold EHC as of Q1 2026.

Cynosure Group reported no remaining Encompass Health position as of Q1 2026 after selling out during the quarter.
Cynosure Group sold 3,578 Encompass Health shares in Q1 2026, an estimated $380K.
Cynosure Group first reported a position in Encompass Health in Q4 2025 and held it in 1 quarter.
Cynosure Group's Encompass Health position peaked at $380K in Q4 2025.
577 funds tracked by Wall St. Rank held Encompass Health as of Q1 2026.

Based on Cynosure Group's 13F filing for Q1 2026, filed 14 May 2026.